Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

BACKGROUND: Although previous studies have evaluated the effect of anti-VEGF therapies for central retinal vein occlusion (CRVO) patients, the majority of previous studies have excluded or included a very small number of patients with ischemic CRVO (iCRVO). The aim of our study is to examine the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Leangelo, Frizzera, Luma Paiva, Coelho, Laura Fernandes, Carricondo, Pedro Carlos, Oyamada, Maria Kiyoko, Pimentel, Sergio Luis Gianotti, Abalem, Maria Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659291/
https://www.ncbi.nlm.nih.gov/pubmed/31372240
http://dx.doi.org/10.1186/s40942-019-0183-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659291/
https://www.ncbi.nlm.nih.gov/pubmed/31372240
http://dx.doi.org/10.1186/s40942-019-0183-x

Ejemplares similares